Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16581 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Jungnam Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Inha University Research.
Abstract (Originalsprache)
Background and Aim Transarterial chemoembolization (TACE) is one of the standard modalities used to treat unresectable hepatocellular carcinoma (HCC), but the effectiveness of TACE for treating patients with a solitary small (≤3 cm) HCC and well‐preserved liver function has not been definitively established. This study aimed to determine the therapeutic impact of TACE in patients with these characteristics.
Methods
This multicenter (four university hospitals) retrospective cohort study analyzed the medical records of 250 patients with a solitary small (≤3 cm) HCC and Child–Turcotte–Pugh (CTP) class A liver function diagnosed over 10 years. Posttreatment outcomes, including overall survival (OS), recurrence‐free survival (RFS), and adverse events, were assessed following TACE therapy.
Results
One hundred and thirty‐eight of the 250 patients (55.2%) treated with TACE achieved complete remission (CR). Overall median OS was 77.7 months, and median OS was significantly longer in the CR group than in the non‐CR group (89.1 vs. 58.8 months, P = 0.001). Median RFS was 19.1 months in the CR group. Subgroup analysis identified hypertension, an elevated serum albumin level, and achieving CR as significant positive predictors of OS, whereas diabetes, hepatitis c virus infection, and tumor size (>2 cm) were poor prognostic factors of OS.
Conclusions
The study demonstrates the effectiveness of TACE as a viable alternative for treating solitary small (≤3 cm) HCC in CTP class A patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea.
- Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
- Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary's Hospital, Incheon, South Korea.
- Department of Internal Medicine, Soonchunhyang University Hospital Bucheon, Bucheon, South Korea.
ORCID-Profile: Young-Joo Jin, Jung Hyun Kwon, Sang Gyune Kim, Young Seok Kim
Förderung
- Inha University Research
Zitieren
APA
Lee, J., Jin, Y. J., Shin, S. K., Kwon, J. H., Kim, S. G., Yu, J. H., Lee, J. W., Kwon, O. S., Nahm, S. W., & Kim, Y. S. (2024). Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16581
Vancouver
Lee J, Jin YJ, Shin SK, Kwon JH, Kim SG, Yu JH, et al. Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16581
BibTeX
@article{Lee2024,
author = {Lee, Jungnam and Jin, Young-Joo and Shin, Seung Kak and Kwon, Jung Hyun and Kim, Sang Gyune and Yu, Jung Hwan and Lee, Jin-Woo and Kwon, Oh Sang and Nahm, Soon Woo and Kim, Young Seok},
title = {Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16581}
}
EUVIMED